article thumbnail

Leveraging Sterile Compounding Technology and Removing Barriers to Improve Safety

Omnicell

And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations. savings per year.

article thumbnail

Elevating Sterile Compounding Accuracy

Omnicell

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why IV Automation Is Critical for Sterile Compounding

Omnicell

So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Dave has been a leader in adoption of IV automation and will share how IV compounding robot and iv workflow solutions are improving safety and helping to reduce errors across all areas of sterile compounding.

article thumbnail

Driving Safety and Savings Through System-Wide Sterile Compounding Automation

Omnicell

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

article thumbnail

Adopting Automation Supports Safer, More Efficient Sterile Compounding

Omnicell

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

article thumbnail

IV Robotics and the Latest USP Revisions

Omnicell

The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day. Subscribe today.

article thumbnail

Driving Pharmacy Value Through Robotics and Connected Technology

Omnicell

Implementing an intelligent infrastructure of automation and intelligence, supported by expert services to ensure optimization, is an opportunity for health systems to enhance medication distribution processes, support sterile compounding safety and efficiency, and ultimately improve pharmacy supply chain management. Subscribe today.